Central hemodynamics are associated with fetal outcomes in pregnancies of advanced maternal age.

Abstract

Age is a known risk factor for both maternal cardiovascular disease and adverse outcomes in pregnancy. We aimed to characterize the hemodynamic profiles in pregnancies of advanced maternal age (AMA) and correlate these with fetal outcomes. This was a prospective observational study of pregnancies undergoing antenatal testing. Maternal hemodynamics were measured non-invasively using an imaging probe at the descending aorta and the Uscom BP+arm cuff utilizing pulse pressure wave analysis. The Wilcoxon rank-sum test, Fisher's exact test, and Spearman rank correlation test were used for statistical analysis in R. Hemodynamic measurements, neonatal birthweight. Twenty-one AMA and twenty-four control patients were enrolled. Mean age±SD was 39±3.22 in the AMA cohort and 28±4.32 in the control cohort (p<0.001). AMA patients were evaluated at a later gestational age (36 4/7 weeks) compared to control (34 1/7 weeks, p=0.02). Between groups, there was no difference in BMI, race, hypertensive disease, diabetes, asthma, drug use, or indication for antenatal testing. 38% (AMA) and 37% (control) had hypertensive disorders of pregnancy. In AMA patients but not control patients, cardiac output (r=0.52, p=0.01), systemic vascular resistance (r=-0.53, p=0.01), and systemic vascular resistance index (r=-0.62, p=0.002) were significantly correlated with neonatal birthweight percentile. Hemodynamic alterations consistent with a low output, high resistance cardiovascular circuit were associated with lower birthweight in AMA, but not in control pregnancies.